FDA Drug Safety Newsletter
This publication provides postmarketing information to healthcare professionals to enhance communication of new drug safety information, raise awareness of reported adverse events, and stimulate additional adverse event reporting.
Current Issue:
Volume 2, Number 2, 2009 HTML | PDF
abrir aquí para acceder al documento en PDF o bien en HTML:
FDA Drug Safety Newsletter
No hay comentarios:
Publicar un comentario